Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation

Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):9994-8. doi: 10.1073/pnas.88.22.9994.

Abstract

SH-SY5Y neuroblastoma cells undergo neuronal differentiation and their proliferation is inhibited when they are treated with phorbol 12-myristate 13-acetate (PMA). Insulin and insulin-like growth factor I (IGF-I) are mitogens for the nontreated SH-SY5Y cells, whereas the proliferative response to such factor stimulation is lost upon differentiation, in spite of the fact that the receptors for insulin and IGF-I remain expressed and functional in the differentiated cells. Here we show that the PMA-induced differentiation of SH-SY5Y cells grown in a serum-free medium is strongly potentiated by nanomolar concentrations of IGF-I, as judged by morphology and markers for neuronal differentiation--e.g., neuropeptide tyrosine and growth-associated protein 43. Also, insulin and IGF-II potentiated the phorbol ester-induced differentiation, although less efficiently than IGF-I. Using blocking anti-receptor antibodies, it could be shown that the differentiation induced by these factors, in combination with PMA, was primarily mediated through the IGF-I receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Northern
  • Blotting, Western
  • Cell Differentiation / drug effects*
  • Cell Division / drug effects*
  • Cell Line
  • Drug Synergism
  • Gene Expression / drug effects
  • Genes, myc
  • Humans
  • Insulin / pharmacology
  • Insulin-Like Growth Factor I / pharmacology*
  • Insulin-Like Growth Factor II / pharmacology
  • Kinetics
  • Neuroblastoma
  • Neurons / cytology*
  • Neurons / drug effects
  • Neuropeptide Y / analysis
  • RNA, Neoplasm / genetics
  • RNA, Neoplasm / isolation & purification
  • Tetradecanoylphorbol Acetate / pharmacology*

Substances

  • Insulin
  • Neuropeptide Y
  • RNA, Neoplasm
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II
  • Tetradecanoylphorbol Acetate